The CMS has published PBM definition guidelines on heamatology oncology conditions. These are are open for stakeholder comments until 30 June 2021. Hodgkin’s lymphoma Cutaneous T-cell lymphoma Multiple Myeloma Acute myeloid leukemia Myelodysplastic syndromes The documents are open for stakeholder comments until the 30th of June